AI Index Funds
AI Enhanced Personalized Medicine Fund

Index Performance

AI Enhanced Personalized Medicine Fund



The integration of artificial intelligence in personalized medicine is revolutionizing healthcare by enabling more precise, efficient, and patient-specific treatment strategies. One of the primary drivers of this theme is the explosion of big data in genomics and patient records, which AI algorithms can analyze to identify patterns and correlations that might otherwise go unnoticed. Additionally, advancements in machine learning and deep learning technologies are enabling more accurate predictive modeling and diagnostic tools. The need for cost-efficient healthcare solutions that provide better patient outcomes is another significant catalyst. Regulatory bodies are gradually embracing AI-driven technologies due to their potential to improve healthcare quality and reduce errors, further accelerating adoption. Lastly, the growing consumer demand for customized healthcare solutions is pushing medical professionals and healthcare facilities to adopt AI to stay competitive. - [[AI-driven Genomics]]: Leveraging AI to analyze genetic data for tailored treatment plans. - [[Predictive Analytics in Healthcare]]: Using AI for early disease detection and risk assessment. - [[AI-powered Diagnostic Tools]]: Development of AI-based systems for accurate and quick diagnosis. - [[AI in Drug Discovery]]: Utilizing AI to streamline the drug discovery and development process. - [[Patient-specific Treatment Planning]]: AI interventions in creating personalized medicine protocols. This index was generated with help from Thematic Analyst.

  • Inception Date06/05/2024
  • WeightingEqual
  • # of holdings25
What's inside?


All holdings as of June 12, 2024
CSV download
Absci Corp. (ABSI)4.54%$510.01M-29.24%-280.40%74.98
Hims & Hers Health, Inc. (HIMS)4.39%$4.55B45.81%68.43%3.50
Ever Fortune.AI Co., Ltd. (6841)4.33%$301.12M359.17%52.10%52.10
Renovaro, Inc. (ENOB)4.30%$215.36MN/AN/AN/A
Simulations Plus, Inc. (SLP)4.20%$920.71M16.22%72.23%11.38
Tenaya Therapeutics, Inc. (TNYA)4.15%$289.73MN/AN/AN/A
OptimizeRx Corp. (OPRX)4.15%$207.36M51.43%56.56%3.09
Recursion Pharmaceuticals, Inc. (RXRX)4.13%$1.97B13.68%-5.60%45.52
CDW Corp. (CDW)4.09%$30.15B-4.51%21.82%1.90
aTyr Pharma, Inc. (LIFE)4.09%$134.57MN/A-227.66%99.16
2seventy Bio, Inc. (TSVT)4.07%$202.02M-70.12%46.88%4.92
Abbott Laboratories (ABT)4.01%$184.07B2.23%50.40%5.13
Medtronic Plc (MDT)4.00%$107.46B3.64%60.59%3.81
Laboratory Corp. of America Holdings (LH)3.98%$16.55B-15.92%26.36%1.98
GE Healthcare Technologies, Inc. (GEHC)3.95%$34.12B-1.21%41.23%2.51
IQVIA Holdings, Inc. (IQV)3.95%$39.27B2.89%27.59%3.90
23andMe Holding Co. (ME)3.94%$133.82M-26.66%31.82%0.51
Kura Oncology, Inc. (KURA)3.93%$1.64BN/AN/AN/A
Quest Diagnostics, Inc. (DGX)3.90%$15.64B1.50%31.91%2.14
Nano-X Imaging Ltd. (NNOX)3.84%$427.56M4.33%-84.25%50.02
Moderna, Inc. (MRNA)3.82%$56.87B-91.07%20.96%6.49
AbCellera Biologics, Inc. (ABCL)3.62%$1.01B-18.36%32.03%18.91
Certara, Inc. (CERT)3.62%$2.46B7.04%45.91%8.14
Adaptive Biotechnologies Corp. (ADPT)3.55%$508.42M11.23%50.35%2.22
Exscientia Plc (EXAI)3.45%$671.88M-4.18%-126.52%13.28
Market data by FactSet